Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Results 101-120 of 158 (Search time: 0.016 seconds).

Issue DateTitleAuthor(s)
101Jan-2013Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinomaSubramaniam, A.; Shanmugam, M.K. ; Perumal, E.; Li, F.; Nachiyappan, A.; Dai, X.; Swamy, S.N.; Ahn, K.S.; Kumar, A.P. ; Tan, B.K.H.; Hui, K.M.; Sethi, G.
102Nov-2011PPARγ disease gene network and identification of therapeutic targets for prostate cancerVenkatachalam, G. ; Kumar, A.P. ; Sakharkar, K.R.; Thangavel, S.; Clement, M.-V. ; Sakharkar, M.K.
103Nov-2017PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.Chen, Luxi ; Yuan, Yi; Kar, Shreya; Kanchi, Madhu M ; Arora, Suruchi; Kim, Ji E; Koh, Pei F ; Yousef, Einas; Samy, Ramar P ; Shanmugam, Muthu K ; Tuan Z ; Shin, Sung W; Arfuso, Frank; Shen, Han M ; Yang, Henry; Goh, Boon C ; Park, Joo I; Gaboury, Louis; Lobie, Peter E ; Sethi, Gautam ; Lim, Lina HK ; Kumar, Alan P 
42009PPRESearch: Peroxisome proliferator activator element search databaseVenkatachalam, G. ; Clement, M.V. ; Sakharkar, M.K.; Kumar, A.P. 
51-Dec-2021Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapyMirzaei, Sepideh; Gholami, Mohammad Hossein; Ang, Hui Li; Hashemi, Farid; Zarrabi, Ali; Zabolian, Amirhossein; Hushmandi, Kiavash; Delfi, Masoud; Khan, Haroon; Ashrafizadeh, Milad; Sethi, Gautam ; Kumar, Alan Prem 
62018Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical reviewSethi, G ; Shanmugam, M.K ; Warrier, S; Merarchi, M; Arfuso, F; Kumar, A.P ; Bishayee, A
73-Aug-2020PTEN, a barrier for proliferation and metastasis of gastric cancer cells: From molecular pathways to targeting and regulationAshrafizadeh, M.; Najafi, M.; Ang, H.L.; Moghadam, E.R.; Mahabady, M.K.; Zabolian, A.; Jafaripour, L.; Bejandi, A.K.; Hushmandi, K.; Saleki, H.; Zarrabi, A.; Kumar, A.P. 
81-Jan-2021Putting the BRK on breast cancer: From molecular target to therapeuticsAng, Hui Li; Yuan, Yi ; Lai, Xianning ; Tan, Tuan Zea ; Wang, Lingzhi ; Huang, Benjamin BoJun; Pandey, Vijay; Huang, Ruby Yun-Ju; Lobie, Peter E ; Goh, Boon Cher ; Sethi, Gautam ; Yap, Celestial T ; Chan, Ching Wan ; Lee, Soo Chin ; Kumar, Alan Prem 
92019Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapyKhattar, E.; Maung, K.Z.Y.; Chew, C.L.; Ghosh, A.; Mok, M.M.H. ; Lee, P. ; Zhang, J.; Chor, W.H.J.; Cildir, G.; Wang, C.Q.; Mohd-Ismail, N.K.; Chin, D.W.L. ; Lee, S.C. ; Yang, H. ; Shin, Y.-J.; Nam, D.-H.; Chen, L.; Kumar, A.P. ; Deng, L.W. ; Ikawa, M.; Gunaratne, J.; Osato, M. ; Tergaonkar, V. 
102009Repression of NHE1 expression by PPARγ activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivoKumar, A.P. ; Quake, A.L. ; Zhou, T.; Pervaiz, S. ; Chang, M.K.X. ; Clement, M.-V. ; Lim, K.S.Y. ; Hewitt, R.E. ; Salto-Tellez, M. ; Singh, R. 
114-Mar-2021Review micrornas as modulators of oral tumorigenesis—a focused reviewRishabh, Kumar; Khadilkar, Soham; Kumar, Aviral; Kalra, Ishu; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.
12Aug-2020Role of microRNA/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancerAshrafizadeh, M.; Hushmandi, K.; Hashemi, M.; Akbari, M.E.; Kubatka, P.; Raei, M.; Koklesova, L.; Shahinozzaman, M.; Mohammadinejad, R.; Najafi, M.; Sethi, G. ; Kumar, A.P. ; Zarrabi, A.
132013Role of NF-κB in tumorigenesisShanmugam, M.K. ; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
142018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M
152018Role of RNF20 in cancer development and progression – a comprehensive reviewSethi, G ; Shanmugam, M.K ; Arfuso, F; Kumar, A.P 
16Dec-2013Secreted frizzled related proteins: Implications in cancersSurana, R.; Sikka, S.; Cai, W.; Shin, E.M.; Warrier, S.R.; Tan, H.J.G.; Arfuso, F.; Fox, S.A.; Dharmarajan, A.M.; Kumar, A.P. 
172017Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cellsThirunavukkarasan M.; Wang C. ; Rao A. ; Hind T.; Teo Y.R.; Siddiquee A.A.-M. ; Goghari M.A.I.; Kumar A.P. ; Herr D.R. 
1815-Dec-2023SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibitionLai, Xianning ; Lui, Sarah Kit Leng ; Lam, Hiu Yan ; Adachi, Yuta; Sim, Wen Jing ; Vasilevski, Natali; Armstrong, Nicola J; Bridgeman, Stephanie Claire; Main, Nathan Michael; Tan, Tuan Zea ; Tirnitz-Parker, Janina EE; Thiery, Jean Paul ; Ebi, Hiromichi; Kumar, Alan Prem ; Eichhorn, Pieter Johan Adam 
192014Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene productsManu, K.A.; Shanmugam, M.K. ; Li, F.; Chen, L.; Siveen, K.S.; Ahn, K.S.; Kumar, A.P. ; Sethi, G.
2018-Feb-2021Small in size, but large in action: Micrornas as potential modulators of pten in breast and lung cancersAbadi, Asal Jalal; Zarrabi, Ali; Gholami, Mohammad Hossein; Mirzaei, Sepideh; Hashemi, Farid; Zabolian, Amirhossein; Entezari, Maliheh; Hushmandi, Kiavash; Ashrafizadeh, Milad; Khan, Haroon; Kumar, Alan Prem